AbbVie Inc. Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
AbbVie Inc. (ABBV) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2013-11-12
- 2013-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-03-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |